RxDoctor Payments Data

Robert Inzer

Obstetrics & Gynecology · Pearl, MSNPI 1497780118

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $10,125 of the $13,220 with a category attached, or 76.6%. Merck accounts for 87.2% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $8,250 and has fallen 99.9% since, to $6 in 2023. Among obstetrics & gynecology clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,220in general payments, 2019–2025

Across 129 payments — averaging $102.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$12K
  • AbbVie$683
  • Mallinckrodt Enterprises LLC$182
  • Pfizer$102
  • Therapeuticsmd, Inc.$97
  • AMAG Pharmaceuticals, Inc.$88
  • plus $535 from 17 others

What the payments were for

  • Speaking & faculty fees$10,12577%
  • Travel & lodging$1,1559%
  • Food & beverage$1,85214%
  • Education$881%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,220 in reported general payments places this provider in the 95th percentile of 318 obstetrics & gynecology providers in Mississippi.

See all obstetrics & gynecology providers in Mississippi

Other obstetrics & gynecology in Pearl

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →